Management of differentiated thyroid cancer in children: Focus on the American Thyroid Association pediatric guidelines

Seminars in Nuclear Medicine

Volumn 46, Issue 2, 2016, Pages 147-164

  Parisi, Marguerite T ^a   Eslamy, Hedieh ^a   Mankoff, David ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; RADIOACTIVE IODINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CHILD; DIFFERENTIATED THYROID CANCER; DISEASE PREDISPOSITION; HUMAN; PATHOGENESIS; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; THYROIDECTOMY; MEDICAL SOCIETY; PATHOLOGY; THYROID NEOPLASMS;

CHILD; DISEASE SUSCEPTIBILITY; HUMANS; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL; THYROID NEOPLASMS;

EID: 84958774543     PISSN: 00012998     EISSN: 15584623     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2015.10.006     Document Type: Review

References (155)

1. R.H. Cobin, H. Gharib, D.A. Bergman, and et al. Thyroid Carcinoma Task Force AACE/AAES medical/surgical guidelines for clinical practice: Management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology Endocr Pract 7 2001 202 220
2. P.P. Perros, K. Boelaert, s. Colley, and et al. Guidelines for the management of Thyroid Cancer. Third Edition. British Thyroid Association Clin Endocrinol (Oxf) 81 1 2014 1 122
3. D.S. Cooper, G.M. Doherty, R.R. Haugen, and et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer Thyroid 19 2009 1167 1214
4. S.F. La Franchi Inaugural management guidelines for children with thyroid nodules and differentiated thyroid cancer: Children are not small adults Thyroid 25 7 2015 713 715 [editorial]
5. G.L. Francis, S.G. Waguespack, A.J. Bauer, and et al. Management Guidelines for children with thyroid nodules and differentiated thyroid cancer. The American Thyroid Association Guidelines Task Force on Pediatric Thyroid Cancer Thyroid 25 7 2015 716 759
6. M.J. Schlumberger Papillary and follicular thyroid cancer N Engl J Med 338 1998 297 306
7. E. Kebebew, P.H.G. Ituarte, A.E. Siperstein, and et al. Medullary thyroid carcinoma. Clinical characteristics, treatment, prognostic factors, and a comparison of staging systems Cancer 88 2000 1139 1148
8. L.B. Vergamini, A.L. Frazier, F.L. Abrantes, and et al. Increase in the incidence of differentiated thyroid cancer in children, adolescents, and young adults: A population-based study J Pediatr 164 2014 1418 1485
9. Ries LAG, Harkins D, Krapcho M, et al (eds): SEER Cancer Statistics Review, 1975-2003. National Cancer Institute, Bethesda, MD. [Available at] http://seer.cancer.gov/csr1975-2003. [Based on November 2005 SEER data posted to the SEER website], 2006
10. Bernstein L, Gurney JG: Carcinomas and other malignant epithelial neoplasms. ICCC XI. Pediatric Monograph. In: Ries LAG, Smith MA, Gurney JG, et al., (eds): Cancer Incidence and Survival Among Children and Adolescents. United States SEER Program 1975-1995. National Cancer institute, SEER Program NIH Pub. No. 99-4649, Bethesda, MD, 1999
11. Waguespack S, Wells S, Ross J, et al. Thyroid cancer. SEER AYA monograph. In: Bleyer WA, O'Leary M, Barr R, et al., (eds): Cancer Epidemiology in Older Adolescents and Young Adults 15-29 years of age, including SEER Incidence and Survival: 1975-2000. [NIH Pub. No. 06-5767, Bethesda, MD]; National Cancer Institute, Bethesda, MD, 2006;143-154. [Also available at] www.seer.cancer.gov/publications
12. Y.E. Demidchik, E.P. Demidchik, C. Reiners, and et al. Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children in Belarus Ann Surg 243 2006 525 532
13. Z.W. Baloch, and V.A. Livolsi Pathology and cytopathology L.E. Braverman, D.S. Cooper, The Thyroid: A Fundamental and Clinical text ed 10 2013 Lippincott Williams & Wilkins Philadelphia, PA 326 353
14. F. Pacini Thyroid cancer in children and adolescents J Endocrinol Invest 25 2002 572 573
15. M.E. Dottorini, A. Vignati, L. Mazzucchelli, and et al. Differentiated thyroid carcinoma in children and adolescents: A 37 year experience in 85 patients J Nucl Med 38 1997 669 675
16. A.J. Sykes, and H.R. Gattamameni Carcinoma of the thyroid in children: A 25 year experience Med Pediatr Oncol 29 1997 103 107
17. D. Landau, L. Vini, R.A. Hern, and et al. Thyroid cancer in children: The Royal Marsden Hospital Experience Eur J Cancer 36 2000 214 220
18. M.W. Ben Arush, M.E. Stein, M. Perez Nahum, and et al. Pediatric thyroid carcinoma: 22 years of experience at the Northern Israel Oncology Center (1973-1995) Pediatr Hematol Oncol 17 2000 85 92
19. A.J. Bauer, R.M. Tuttle, and G.L. Francis Differentiated thyroid carcinoma of children and adolescents Endocrinologist 12 2002 135 142
20. C. Arici, O. Erdogan, H. Altunbas, and et al. Differentiated thyroid carcinoma in children and adolescents Horm Res 57 2002 153 156
21. I.D. Hay, T. Gonzalez-Losada, M.S. Reinalda, and et al. Long-term outcome in 215 children and adolescents with papillary thyroid carcinoma treated during 1940-2008 World J Surg 34 2010 1192 1202
22. M. Pawelczak, R. David, B. Franklin, and et al. Outcomes of children and adolescents with well-differentiated thyroid carcinoma and pulmonary metastases following I-131 treatment: A systemic review Thyroid 20 2010 1095 1101
23. S.G. Waguespack, and S.A. Wells Thyroid cancer A.W. Bleyer, R.D. Barr, Cancer in Adolescents and Young Adults 2007 Springer, Breslin, Heidelberg New York 259 270
24. X.C. Wu, V.W. Chen, B. Steele, and et al. Cancer incidence in adolescents and young adults in the United States, 1992-1997 J Adolesc Health 32 2003 405 415
25. A.R. Hogan, Y. Zhuge, E.A. Perez, and et al. Pediatric thyroid carcinoma: Incidence and outcomes in 1753 patients J Surg Res 156 2009 167 172
26. M.L. Brandi, R.F. Gagel, A. Angeli, and et al. Guidelines for the diagnosis and therapy of MEN type 1 and type 2 J Clin Endocrinol Metab 86 2001 5658 5671
27. H. Donis-Keller, S. Dou, D. Chi, and et al. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC Hum Mol Genet 2 1993 851 856
28. S.M. Jhiang, L. Fithian, C.M. Weghorst, and et al. RET mutation screening in MEN2 patients and discovery of a novel mutation in a sporadic medullary thyroid carcinoma Thyroid 6 1996 115 121
29. F. Pacini, R. Elisei, C. Romei, and et al. RET proto-oncogene mutations in thyroid carcinomas: Clinical relevance J Endocrinol Invest 23 2000 328 338
30. S. Yamashita, and V. Saenko Mechanisms of disease: Molecular genetics of childhood thyroid cancers Nat Clin Pract Endocrinol Metab 3 2007 422 429
31. K. Penko, J. Livezey, C. Fenton, and et al. BRAF mutations are uncommon in papillary thyroid cancer of young patients Thyroid 15 2005 320 325
32. E.T. Kimura, M.N. Nikiforova, Z. Zhu, and et al. High prevalence of BRAF mutations in thyroid cancer: Genetic evidence for constitutive activation of the RET/PTC-RAD-BRAF signaling pathway in papillary thyroid carcinoma Cancer Res 63 2003 1454 1457
33. M. Sobrinho-Simoes, V. Maximo, A.S. Rocha, and et al. Iatrogenic mutations in thyroid cancer Endocrinol Metab Clin North Am 37 2008 333 362
34. B.J. Duffy, and P.J. Fitzgerald Cancer of the thyroid in children: A report of 28 cases J Clin Endocrinol Metab 10 1950 1296 1308
35. D.E. Clark Association of irradiation with cancer of the thyroid in children and adolescents J Am Med Assoc 159 1955 1007 1009
36. L.N. Parker, J.L. Belsky, T. Yamamoto, and et al. Thyroid carcinoma after exposure to atomic radiation: A continuing survey of a fixed population Hiroshima and Nagasaki, 1958-1971 Ann Intern Med 80 1974 600 674
37. C.J. Johnson Cancer incidence in an area of radioactive fallout downwind from the Nevada test site J Am Med Assoc 251 1984 230 236
38. T.E. Hamilton, G. van Belle, and J.P. LoGerfo Thyroid neoplasia in Marshall Islanders exposed to nuclear fallout J Am Med Assoc 258 1987 629 636
39. T. Winship, and R.V. Rosvall Thyroid carcinoma in childhood: Final report of a 20 year study Clin Proc Children's Hosp Washington, DC 26 1970 327 349
40. I. Morimoto, Y. Yoshimoto, K. Sako, and et al. Serum TSH, thyroglobulin, and thyroidal disorders in atomic bomb survivors exposed in youth: 30 year follow-up study J Nucl Med 28 1987 1115 1122
41. Y. Nikiforov, and D.R. Gnepp Pediatric thyroid cancer after the Chernobyl disaster Cancer 74 1994 748 766
42. V.S. Kazakov, E.P. Demidchik, and L.N. Astakhova Thyroid cancer after Chernobyl Nature 359 1992 21
43. A. Faggiano, J. Coulot, N. Bellon, and et al. Age-dependent variation in follicular size and expression of iodine transporters in human thyroid tissue J Nucl Med 45 2004 232 237
44. E. Ron, J.H. Lubin, R.E. Shore, and et al. Thyroid cancer after exposure to external radiation: A pooled analysis of seven studies Radiat Res 141 1995 259 277
45. B. Sinnott, E. Ron, and A.B. Schneider Exposing the thyroid to radiation: A review of its current extent, risks and implications Endocr Rev 31 5 2010 756 773
46. A.J. Sigurdson, C.M. Ronckers, A.C. Mertens, and et al. Primary thyroid cancer after a first tumor in childhood (the Childhood Cancer Survivor Study): A nested case-control study Lancet 365 2005 2014 2023
47. C.M. Ronkers, A.J. Sigurdson, M. Stovall, and et al. Thyroid cancer in childhood cancer survivors: A detailed evaluation of radiation dose response and its modifiers Radiat Res 166 2006 618 628
48. J.P. Neglia, D.L. Friedman, Y. Yasui, and et al. Second malignant neoplasms in five year survivors of childhood cancer: Childhood cancer survivor study J Natl Cancer Inst 93 2001 618 629
49. A.M. Meadows, Friedman Dl, J.P. Neglia, and et al. Second neoplasms in survivors of childhood cancer: Findings from the Childhood Cancer Survivor Study Cohort J Clin Oncol 27 2009 2356 2362
50. P. Bhatti, L.H.S. Veiga, C.M. Ronckers, and et al. Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: An update from the Childhood Cancer Survivor Study Radiat Res 174 6 2010 741 752
51. A.R. Lafferty, and J.A. Batch Thyroid nodules in children and adolescents: Thirty years of experience J Pediatr Endocrinol Metab 10 1997 479 486
52. W. Hung Solitary thyroid nodules in 93 children and adolescents, a 35 year experience Horm Res 52 1999 15 18
53. H. Gharib, and E. Papini Thyroid nodules: Clinical importance, assessment, and treatment Endocrinol Metab Clin North Am 36 2007 707 735
54. L. Kaloumenou, M. Alevizaki, C. Lodopoulos, and et al. Thyroid volume and echostructure in schoolchildren living in an iodine replete area: Relation to age, pubertal stage, and body mass Thyroid 2007 875 891
55. E.L. Mazzaferri Management of a solitary nodule N Engl J Med 328 1993 553 559
56. L. Hegedus The thyroid nodule N Engl J Med 51 2004 1764 1771
57. M. Niedziela Pathogenesis, diagnosis, and management of thyroid nodules in children Endocr Relat Cancer 13 2006 427 453
58. A. Gupta, S. Ly, L.A. Castroneves, and et al. A standardized assessment of thyroid nodules in children confirms higher cancer prevalence than adults J Clin Endocrinol Metab 98 2013 3238 3245
59. C.A. Dinauer, and G.L. Francis Thyroid cancer in children Endocrinol Metab Clin North Am 36 2007 779 806
60. A. Lyshchik, V. Drozd, Y. Demidchik, and et al. Diagnosis of thyroid cancer in children: Value of Gray-scale and Power Doppler US Radiology 235 2005 604 613
61. J.G. Desjardins, A.H. Khan, P. Montupet, and et al. Management of thyroid nodules in children: A 20 year experience J Pediatr Surg 22 1987 736 739
62. A. Yastovich, J.M. Laberge, C. Rodd, and et al. Cystic thyroid lesions in children J Pediatr Surg 33 1998 866 870
63. J.B. Ogilivie, E.J. Piatigorski, and O.H. Clark Current status of fine needle aspiration for thyroid nodules Adv Surg 40 2006 223 238
64. A. Corrias, S. Einaudi, E. Chioboli, and et al. Accuracy of fine needle aspiration biopsy of thyroid nodules in detecting malignancy in childhood: Comparison with conventional, clinical, laboratory, and imaging approaches J Clin Endocrinol Metab 86 2001 4644 4648
65. H. Gharib, D. Zimmerman, J.R. Goeller, and et al. Fine needle aspiration biopsy: Use in diagnosis and management of pediatric thyroid diseases Endocr Pract 1 1995 9 13
66. M. Smith, L. Pantanowitz, W.E. Khalbuss, and et al. Indeterminant pediatric fine needle aspirations: A study of 68 cases Acta Cytol 57 2013 341 348
67. S. Dremier, F. Coppee, F. Delange, and et al. Clinical review 84: Thyroid autonomy: Mechanism and clinical effects J Clin Endocrinol Metab 81 1996 4187 4193
68. M. Niedziela, D. Breborowicz, E. Trejster, and et al. Hot nodules in children and adolescents in western Poland from 1996-2000: Clinical analysis of 31 patients J Pediatr Endocrinol Metab 15 2002 823 830
69. J.M. Stulak, C.S. Grant, D.R. David, and et al. Value of preoperative ultrasonography in the surgical management of initial and re-operative papillary thyroid cancer Arch Surg 141 2006 489 496
70. M.A. Kouvaraki, S.E. Shapiro, B.D. Fornage, and et al. Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer Surgery 134 2003 946 955
71. H.E. Gonzalez, F. Cruz, A. O'Brien, and et al. Impact of preoperative ultrasonographic staging of the neck in papillary thyroid cancer Arch Otolaryngol Head Neck Surg 133 12 2007 1258 1262
72. R. Vassilopoulou-Sellin, M.J. Klein, T.H. Smith, and et al. Pulmonary metastases in children and young adults with differentiated thyroid cancer Cancer 71 1993 1348 1352
73. J.S. Brink, J.A. van Heerden, B. McIver, and et al. Papillary thyroid cancer with pulmonary metastases in children: Long-term prognosis Surgery 128 2000 881 886
74. B. Schluter, B.H. Bohuslavizki, W. Beyer, and et al. Impact of FDG PET on patients who present with elevated thyroglobulin and negative 131-I scan J Nucl Med 42 2001 71 76
75. M.J. Dong, Z.F. Liu, K. Zhao, and et al. Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine negative whole-body scan: A meta-analysis Nucl Med Commun 30 2009 639 650
76. C. Rubino, F. de Vathaire, M.E. Dottorini, and et al. Second primary malignancies in thyroid cancer patients Br J Cancer 89 2003 1638 1644
77. A.P. Brown, J. Chen, Y.J. Hitchcock, and et al. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer J Clin Endocrinol Metab 93 2008 504 515
78. 2010 Thyroid S.B. Edge, D.R. Byrd, C.C. Compton, and et al. AJCC Cancer Staging Manual ed 7 2010 Springer New York, NY 87 96
79. C.A. Welch Dinauer, R.M. Tuttle, D.K. Robie, and et al. Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents, and young adults Clin Endocrinol 49 1998 619 628
80. B. Jarzab, D. Handkiewicz-Junak, J. Wolch, and et al. Multivariate analysis of prognostic factors for differentiated thyroid cancer in children Eur J Nucl Med 27 2000 833 841
81. Wloch J Handkiewicz-Junak, J. Roskosz, and et al. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer J Nucl Med 48 2007 879 888
82. M. Bingol-Kologu, F.C. Tanyel, M.E. Senocak, and et al. Surgical treatment of differentiated thyroid cancer in children Eur J Pediatr Surg 10 2000 347 352
83. B. Jarzab, D. Handkiewicz-Junak, and J. Wolch Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: A qualitative review Endocr Relat Cancer 12 2005 773 803
84. S.E. Carty, D.S. Cooper, G.M. Doherty, and et al. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer Thyroid 19 2009 1153 1158
85. A.E. Bargren, G.Y. Meyer-Rochow, L.W. Delbridge, and et al. Outcomes of surgically managed pediatric thyroid cancer J Surg Res 156 2009 70 73
86. A. Kundel, G.B. Thompson, M.L. Richards, and et al. Pediatric endocrine surgery: A 20 year experience at the Mayo Clinic J Clin Endocrinol Metab 99 2014 399 406
87. M.P. La Quaglia, T. Black, G.W. Holcomb, and et al. Differentiated thyroid cancer: Clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group J Pediatr Surg 35 2000 955 960
88. R. Savio, J. Gosnell, F. Palazzo, and et al. The role of a more extensive surgical approach in the initial multimodality management of papillary thyroid cancer in children J Pediatr Surg 40 2005 1696 1700
89. J.A. Sosa, C.T. Tuggle, T.S. Wang, and et al. Clinical and economic outcomes if thyroid and parathyroid surgery in children J Clin Endocrinol Metab 93 2008 3058 3065
90. C.T. Tuggle, S.A. Roman, T.S. Wang, and et al. Pediatric endocrine surgery: Who is operating on our children Surgery 144 2008 869 877
91. M. Luster, F. Lippi, B. Jarzab, and et al. rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: A comprehensive review Endocr Relat Cancer 12 2005 49 64
92. W.F. Lau, M.R. Zacharin, K. Waters, and et al. Management of paediatric thyroid carcinoma: Recent experience with recombinant human thyroid stimulating hormone in preparation for radioiodine therapy Intern Med J 36 2006 564 570
93. M. Luster, D. Handkiewicz-Junak, A. Grossi, and et al. Recombinant thyrotropin use in children and adolescents with differentiated thyroid cancer: A multicenter retrospective study J Clin Endocrinol Metab 94 2009 3948 3953
94. M.T. Parisi, and D.M. Mankoff Differentiated pediatric thyroid cancer: Correlates with adult disease, controversies in treatment Semin Nucl Med 37 2007 340 356
95. E.L. Mazzaferri, R.J. Robbins, C.A. Spencer, and et al. Consensus report of the role of serum thyroglobulin as a monitoring method for low risk patients with papillary thyroid carcinoma J Clin Endocrinol Metab 88 2003 1433 1441
96. W. Brenner Is thyroid stunning a real phenomenon or just fiction J Nucl Med 43 2002 835 836
97. S.J. Mandel, A.K. Shanker, F. Bernard, and et al. Superiority of iodine-123 compared to iodine-131 scanning for thyroid remnants in patients with differentiated thyroid cancer Clin Nucl Med 26 2001 6 9
98. M. Urhan, S. Dadparvar, A. Mavi, and et al. Iodine -123 as a diagnostic imaging agent in differentiated thyroid carcinoma: A comparison with iodine-131 post-treatment scanning and serum thyroglobulin measurement Eur J Nucl Med Mol Imaging 34 2007 1012 1017
99. H.Y. Kim, M.J. Gelfand, and S.E. Sharp SPECT/CT imaging in children with papillary thyroid carcinoma Pediatr Radiol 41 2011 1008 1012
100. E.L. Mazzaferri, and R.T. Kloos Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer J Clin Endocrinol Metabol 86 2001 1447 1463
101. 131I therapy of thyroid cancer patients Q J Nucl Med 43 1999 324 335
102. D. Van Nostrand The benefits and risks of I-131 therapy in patients with well differentiated thyroid cancer Thyroid 2009 1381 1391
103. R.J. Robbins, and M.J. Schlumberger The evolving role of 131- I for the treatment of differentiated thyroid carcinoma J Nucl Med 46 suppl 1 2005 28S 37S (suppl)
104. M. Schlumberger, B. Catargi, I. Borget, and et al. Strategies of radioiodine ablation in patients with low-risk thyroid cancer N Engl J Med 366 2012 1663 1673
105. I.D. Hay, G.B. Thompson, C.S. Grant, and et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): Temporal trends in initial therapy and long-term outcome in 2444consecutively treated patients World J Surg 26 2002 879 885
106. J. Jonklaas, D.S. Cooper, K.B. Ain, and et al. Radioiodine therapy in patients with stage I differentiated thyroid cancer Thyroid 20 2010 1423 1424
107. R.M. Tuttle, R. Leboeuf, and A.R. Shaha Medical management of thyroid cancer: A risk adapted approach J Surg Oncol 97 2008 712 716
108. N.G. Iyer, L.G.T. Morris, M. Tuttle, and et al. Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy Cancer 117 2011 4439 4446
109. S.A. Rivkees, E.L. Mazzaferri, F.A. Verberg, and et al. The treatment of differentiated thyroid cancer in children: Emphasis on surgical approach and radioactive iodine therapy Endocrine Reviews 32 2011 798 826
110. K.D. Newman, T. Black, Heller, and et al. Differentiated thyroid cancer: Determinants of disease progression in patients <21 years of age at diagnosis: A report from the Surgical Discipline Committee of the Children's Cancer Group Ann Surg 227 1998 533 541
111. E.L. Mazzaferri, and S.M. Jhiang Long-term impact of initial surgery and medical therapy on papillary and follicular thyroid cancer Am J Med 1994 418 428
112. F. Pacini, P.W. Ladenson, M. Schlumberger, and et al. Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: Results of an international randomized controlled study J Clin Endocrinol Metab 91 2006 926 932
113. S.M. Chow, S.C. Law, W.M. Mendenhall, and et al. Differentiated thyroid carcinoma in childhood and adolescence - Clinical course and the role of radioiodine Pediatr Blood Cancer 42 2004 176 183
114. D. Guiffrida, C. Scollo, G. Pellegriti, and et al. Differentiated thyroid cancer in children and adolescents J Endocrinol Invest 25 2002 18 24
115. W. Hung, and N.J. Sarlis Current controversies in the management of pediatric patients with well-differentiated non-medullary thyroid cancer: A review Thyroid 12 2002 683 702
116. B. Catz, D. Petit, and P. Starr The diagnostic and therapeutic value of thyrotropic hormone and heavy dosage scintigram for the demonstration of thyroid cancer metastases Am J Med Sci 237 1959 158 164
117. J. Nemec, S. Rohling, V. Zamrazil, and et al. Comparison of the distribution of diagnostic and thyroablative I-131 in the evaluation of differentiated thyroid cancers J Nucl Med 20 1979 92 97
118. A. Waxman, L. Ramanna, L. Chapman, and et al. The significance of I-131 scan dose in patients with thyroid cancer: Determination of ablation J Nucl Med 22 1981 861 865
119. E. Kebebew, and O.H. Clark Differentiated thyroid cancer: Complete rational approach World J Surg 24 2000 942 951
120. D. van Nostrand, J. Neutz, and F. Atkins Side-effects of rational dose iodine-131 therapy for metastatic well-differentiated thyroid carcinoma J Nucl Med 27 1986 1519 1527
121. C.J. Edmonds, and T. Smith The long term hazards of the treatment of thyroid cancer with radioiodine Br J Radiol 59 1986 45 51
122. S.J. Mandel, and L. Mandel Radioactive iodine and the salivary glands Thyroid 13 2003 265 271
123. R.K. Grewal, S.M. Larson, C.E. Pentlow, and et al. Salivary gland side effects commonly develop several weeks after initial radioactive iodine ablation J Nucl Med 50 2009 1605 1610
124. S.L. Lee Complications of radioactive iodine treatment of thyroid carcinoma J Natl Compr Canc Netw 8 2010 1277 1286
125. J. Klubo-Gwiezdzinska, D. van Nostrand, K.D. Burman, and et al. Salivary gland malignancy and radioiodine therapy for thyroid cancer Thyroid 20 2010 647 651
126. M.A. Walter, C.P. Turtschi, C. Schindler, and et al. The dental safety profile of high-dose radioiodine therapy for thyroid cancer: Long-term results of a longitudinal cohort study J Nucl Med 48 2007 1620 1625
127. F.A. Verberg, H. Hanscheid, J. Biki, and et al. Dosimetry-guided high activity I(131) therapy in patients with advanced differentiated thyroid carcinoma: Initial experience Eur J Nucl Med Mol Imaging 37 2010 896 903
128. M.E. Dottorini Genetic risks after I-131 exposure: An opportunity and obligation for nuclear medicine J Nucl Med 37 1996 612 614
129. L. Vini, S. Hyer, A. Al-Saadi, and et al. Prognosis for fertility and ovarian function after treatment with radioiodine for thyroid cancer Postgrad Med J 78 2002 92 93
130. J.P. Raymond, M. Izembart, V. Marliac, and et al. Temporary ovarian failure in thyroid cancer patients after thyroid remnant ablation with radioactive iodine J Clin Endocrinol Metab 69 1989 186 189
131. M.B. Smith, H. Xue, H. Takahashi, and et al. Iodine-131 thyroid ablation in female children and adolescents: Long-term risk of infertility and birth defects Ann Surg Oncol 1 1994 128 131
132. M. Schlumberger, F. de Vathaire, C. Ceccarelli, and et al. Outcome of pregnancy in women with thyroid cancer J Endocrinol Invest 18 1995 150 151
133. M. Schlumberger, F. de Vathaire, C. Ceccarelli, and et al. Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients J Nucl Med 37 1996 606 612
134. A.M. Sawka, D.C. Lakra, J. Lea, and et al. A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female cancer survivors Clin Endocrinol 68 2008 479 490
135. J.P. Garsi, M. Schlumberger, C. Rubino, and et al. Therapeutic administration of 131I for differentiated thyroid cancer: Radiation dose to the ovaries and outcome of pregnancies J Nucl Med 49 2008 845 852
136. C. Ceccarelli, W. Bencivelli, D. Morciano, and et al. 131-I therapy for differentiated thyroid cancer leads to an earlier onset of menopause: Results of a retrospective study J Clin Endocrinol Metab 86 2001 3512 3515
137. D. Casara, D. Rubella, G. Saldini, and et al. Pregnancy after high therapeutic doses of iodine-131 in differentiated thyroid cancer: Potential risks and recommendations Eur J Nucl Med 20 1993 192 194
138. F. Pacini, M. Gasperi, L. Fugazzola, and et al. Testicular function in patients with differentiated thyroid cancer treated with radioiodine J Nucl Med 35 1994 1418 1422
139. P.W. Rosario, A.L. Barroso, L.L. Rezende, and et al. Testicular function after radioiodine therapy in patients with thyroid cancer Thyroid 16 2006 667 670
140. A.M. Sawka, J. Lea, B. Alshehri, and et al. A systematic review of the gonadal effects of therapeutic radioactive iodine in male thyroid cancer survivors Clin Endocrinol 68 2008 610 617
141. S. Hyer, L. Vini, M. O'Connell, and et al. Testicular dose and fertility in men following I(131) therapy for thyroid cancer Clin Endocrinol 56 2002 755 758
142. W.H. Wallace Oncofertility and preservation of reproductive capacity in children and young adults Cancer 117 2011 2301 2310
143. S.D. Sarker, W.H. Bierewaltes, S.P. Gill, and et al. Subsequent fertility and birth histories of children and adolescents treated with I-131 for thyroid cancer J Nucl Med 17 1976 460 464
144. L. Baugnet-Mathieu, M. Lemaire, E.D. Leonard, and et al. Chromosome aberrations after treatment with radioactive iodine for thyroid cancer Radiat Res 140 1994 429 431
145. S. Gutierrez, E. Carbonell, P. Galofre, and et al. Cytogenic damage after I-131 treatment for hyperthyroidism and thyroid cancer: A study using the micronucleus test Eur J Nucl Med 26 12 1999 1589 1596
146. S. Puerto, R. Marcos, M.J. Ramirez, and et al. Equal induction and persistence of chromosome aberrations involving chromosomes 1, 4, and 10 in thyroid cancer patients treated with radioactive iodine Mutat Res 469 2000 147 158
147. H. Brinker, H.S. Hansen, and A.P. Anderson Induction of leukemia by 131-I treatment of thyroid cancer Br J Cancer 28 1973 232 237
148. D.A. Hoffmann, W.M. McConahey, J.F. Fraumeni, and et al. Cancer incidence following treatment of hyperthyroidism Int J Epidemiol 11 1982 218 224
149. A.P. Brown, J. Chen, Y.J. Hitchcock, and et al. The risk of second malignancies up to three decades after the treatment of differentiated thyroid cancer J Clin Endocrinol Metab 93 2008 504 515
150. M. Schlumberger, G. Berg, O. Cohen, and et al. Follow-up of low-risk patients with differentiated thyroid carcinoma: A European prospective Eur J Endocrinol 150 2004 105 112
151. R.T. Kloos Thyroid cancer recurrence in patients clinically free of disease with undetectable or very low serum thyroglobulin levels J Clin Endocrinol Metab 95 2010 5241 5248
152. C. Spencer, S. Fatemi, P. Singer, and et al. Serum basal thyroglobulin measured by a second-generation assay correlates with the recombinant human thyrotropin-stimulated thyroglobulin response in patients treated for differentiated thyroid cancer Thyroid 20 2010 587 595
153. R.T. Kloos, and E.L. Mazzaferri A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later J Clin Endocrinol Metab 90 2005 5047 5057
154. B. Schaadt, U. Felt-Rasmusson, B. Rasmusson, and et al. Assessment of the influence of thyroglobulin (Tg) autoantibodies and other interfering factors on the use of serum Tg as a tumor marker in differentiated thyroid carcinoma Thyroid 5 1995 165 170
155. F.A. Vergberg, M. Luster, C. Cupini, and et al. Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: A clinical position statement Thyroid 23 2013 12111225